Pancreatic Cell News Volume 15.00 | Jan 9 2024

    0
    14








    2024-01-09 | PACN 15.01


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 15.00 – 9 January, 2024
    TOP STORY

    EGFR-Activated Myofibroblasts Promote Metastasis of Pancreatic Cancer

    Inhibition of an epidermal growth factor receptor/Erb-B2 receptor (EGFR/ERBB2)-signaling network in PDAC organoid-derived cultures and mouse models differentially impacted distinct cancer-associated fibroblasts subtypes, providing insights into mechanisms underpinning their heterogeneity.
    [Cancer Cell]

    Full ArticleGraphical Abstract
    Tools to isolate, culture, and assay cells. Click to explore.
    PUBLICATIONSRanked by the impact factor of the journal

    Ghrelin Deletion and Conditional Ghrelin Cell Ablation Increase Pancreatic Islet Size in Mice

    Scientists demonstrated that reducing ghrelin — by ghrelin gene knockout, conditional ghrelin cell ablation, or high-fat diet feeding — was associated with increased mean islet size, percentage of large islets, and β cell cross-sectional area.
    [Journal Of Clinical Investigation]

    Full ArticleGraphical Abstract

    A Role and Mechanism for Redox Sensing by SENP1 in β-Cell Responses to High Fat Feeding

    The authors showed, in β-cells from overweight humans without diabetes and mice fed a high-fat diet for two days, insulin exocytosis and secretion were enhanced without increased Ca2+ influx.
    [Nature Communications]

    Full Article

    S100A9 Exerts Insulin-Independent Antidiabetic and Anti-Inflammatory Effects

    Researchers reported an insulin signaling–independent pathway able to improve glycemic control in type 1 diabetes mellitus rodents.
    [Science Advances]

    Full Article

    Regulation of Multiple Signaling Pathways Promotes the Consistent Expansion of Human Pancreatic Progenitors in Defined Conditions

    The authors showed that the combined stimulation of specific mitogenic pathways, suppression of retinoic acid signaling, and inhibition of selected branches of the TGFβ and Wnt signaling pathways were necessary for the effective decoupling of pancreatic progenitors proliferation from differentiation.
    [eLife]

    Full Article

    Insulin Regulates Human Pancreatic Endocrine Cell Differentiation In Vitro

    Differentiation of induced pluripotent stem cells (iPSC) into the pancreatic and endocrine lineage, combined with immunostaining, Western blotting and proteomics analysis, phenotypically characterized the insulin gene deficiency in SC-islets.
    [Molecular Metabolism]

    Full Article

    A Pancreatic Cancer Organoid Platform Identifies an Inhibitor Specific to Mutant KRAS

    Scientists reported a high-throughput drug-screening platform using a series of isogenic murine pancreatic organoids that were wild type or contain common PDAC driver mutations, representing both classical and basal PDAC phenotypes.
    [Cell Stem Cell]

    AbstractGraphical Abstract

    Engrailed-1 Promotes Pancreatic Cancer Metastasis

    Engrailed-1 predominantly repressed its target genes through direct binding to gene enhancers and promoters, implicating roles in the activation of MAPK pathways, and the acquisition of mesenchymal cell properties.
    [Advanced Science]

    Full Article

    Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients with Type 2 Diabetes

    Pancreatic cancer incidence was compared according to weighted cumulative exposures to glucagon-like peptide-1 receptor agonists and to basal insulin in a Cox model implemented in discrete time, with time origin at two years after diabetes diagnosis, adjusting for confounding.
    [Jama Network Open]

    Full Article
    View tips on how to organize your lab notebooks, references and protocols.
    REVIEWS

    Recent Advances in Drug Delivery and Targeting for the Treatment of Pancreatic Cancer

    Scientists discuss how the complexity of various tumor microenvironment components and the oncogenic signaling pathways that they are connected to actively contribute to the development and spread of PDAC, as well as the ways that recent therapeutic approaches have been targeted to restore it.
    [Journal Of Controlled Release]

    AbstractGraphical Abstract

    The Application of Organoid Models in Research Into Metabolic Diseases

    The authors focus on the construction process and research progress with regard to organoids related to metabolic diseases in recent years, and looks forward to their prospective applications.
    [Diabetes Obesity & Metabolism]

    Full Article
    INDUSTRY AND POLICY NEWS

    Drugmakers Set to Raise US Prices on at Least 500 Drugs in January

    The expected price hikes come as the pharmaceutical industry gears up for the Biden Administration to publish significantly discounted prices for 10 high-cost drugs in September, and continues to contend with higher inflation and manufacturing costs.
    [Reuters]

    News Article
    FEATURED EVENT

    Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®

    February 21 – 24, 2024
    San Antonio, Texas, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Beta Cell & Adipose Biology

    Weill Cornell Medicine – New York City, New York, United States

    Assistant/Associate/Full Professor – Cancer Stem Cell Biology & Cancer Nanotechnology

    Michigan State University – East Lansing, Michigan, United States

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    Postdoctoral Scholar – iPSC Disease Modeling

    University of California San Francisco – San Francisco, California, United States

    Animal Technician – Experimental Therapeutics

    BC Cancer – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2